MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-AP-20-0001188
Ekard Life Sciences Private Limited
Ekard Life Sciences Private Limited - pharma in Secunderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2023
₹4.2 Cr
▲ 35% YoY
Net profit · FY 2023
₹2.58 Lakh
Net margin 0.6%
EBITDA · FY 2023
₹4.24 Lakh
EBITDA margin 1%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
13 yrs
Est. 2013
Directors on board
2
As per MCA filings
Active GSTINs
2
GST registered
About Ekard Life Sciences Private Limited
Data last updated:
Ekard Life Sciences Private Limited is a private limited company based in Secunderabad, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 19 August 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24100TG2013PTC089575. Its GSTIN is 36AADCE4658C1ZS (Telangana). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Jayantilal Bhandari and Borra Udayabaskar.
Its last annual general meeting (AGM) was held on 29 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at # 7 – 1 – 497 Monda Market Bandimetta, Secunderabad, Telangana, India – 500003.
As per the financials filed for FY 2023, the company reported a revenue of ₹4.2 Cr, a growth of 35% compared to the previous year. For the same year it recorded a net profit of ₹2.58 Lakh (net margin 0.6%) and EBITDA of ₹4.24 Lakh (EBITDA margin 1%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 8% over five years.
Ekard Life Sciences Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-AP-20-0001188). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24100TG2013PTC089575
Registration Number 089575
Incorporation Date 19 August 2013
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-AP-20-0001188
CIN history
Ekard Life Sciences has one previous CIN (Corporate Identification Number): U24100AP2013PTC089575. The current CIN is U24100TG2013PTC089575, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24100TG2013PTC089575 | Current |
| U24100AP2013PTC089575 | Previous |
Recognitions & Rankings of Ekard Life Sciences
Contact details
Ekard Life Sciences Private Limited's registered office is in Secunderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address# 7 – 1 – 497 Monda Market Bandimetta, Secunderabad, Telangana, India – 500003
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Ekard Life Sciences Private Limited, buy the company report.
Comprehensive company report
Ekard Life Sciences Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Ekard Life Sciences is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Ekard Life Sciences Private Limited, buy the company report.
Financials of Ekard Life Sciences Private Limited
FY 2023 filings availableEkard Life Sciences Private Limited reported revenue of ₹4.2 Cr (up 35% YoY) for FY 2023.
Revenue · FY 2023
₹4.2 Cr ▲ 35%
Net profit · FY 2023
₹2.58 Lakh margin 0.6%
EBITDA · FY 2023
₹4.24 Lakh margin 1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 35%
3 years · compounded
▲ 2%
5 years · compounded
▲ 8%
EBITDA CAGR growth
1 year
▲ 40%
3 years · compounded
▼ 3%
5 years · compounded
▲ 5%
Revenue has grown at a compounded annual rate (CAGR) of 8% over five years, including 35% growth in the latest year. EBITDA rose 40% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹4.2 Cr | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.24 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.58 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1% | ||||
| Net Profit Margin | 0.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ekard Life Sciences Private Limited, buy the company report.
Board of directors of Ekard Life Sciences Private Limited
Ekard Life Sciences has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jayantilal Bhandari | Director | 19 Aug 2013 | 13 Years 2 Months | Current |
| Borra Udayabaskar Also directs: Verlen Labs Private Limited | Director | 19 Aug 2013 | 13 Years 2 Months | Current |
Peer comparison
Ekard Life Sciences Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Spenchem Pharmaceuticals Private Limited | ₹4.21 Cr (FY 2025) | 3.0% | Kozhikode, Kerala, India | |||
| Maxford Labs Private Limited | ₹4.21 Cr (FY 2025) | 26.0% | Hyderabad, Telangana, India | |||
| Ekard Life Sciences Private Limitedthis company | ₹4.2 Cr (FY 2023) | ₹2.58 Lakh | 0.6% | 35.0% | Secunderabad, Telangana, India | |
| Fab Pharmaceuticals Private Limited | ₹4.18 Cr (FY 2025) | -29.0% | Bangalore, Karnataka, India | |||
| Zaneka Pharmaceuticals Private Limited | ₹4.17 Cr (FY 2025) | -3.0% | Haridwar, Uttarakhand, India |
To see the full peer comparison of Ekard Life Sciences Private Limited, buy the company report.
Auditor
Ekard Life Sciences Private Limited is audited by VISHNUPRIYA & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| VISHNUPRIYA & CO | FY 2023 | 222366 |
Shareholding
The shareholding of Ekard Life Sciences Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Ekard Life Sciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Ekard Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ekard Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Ekard Life Sciences has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AADCE4658C1ZS | Telangana | Active | 01 Jul 2017 |
| 37AADCE4658C1ZQ | Andhra Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Ekard Life Sciences Private Limited, buy the company report.
Recent activity
Ekard Life Sciences Private Limited has 2 board changes on record since 2013: 2 appointments. The latest: Borra Udayabaskar was appointed as Director on 19 Aug 2013.
AGM
Ekard Life Sciences Private Limited last Annual general meeting of members was held on 29 Sep 2023 as per latest MCA records.
Filing
Ekard Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad.
Appointed
Borra Udayabaskar was appointed as Director.
Appointed
Jayantilal Bhandari was appointed as Director.
Incorporation
19 Aug 2013
Ekard Life Sciences Private Limited was registered on 19 Aug 2013 with Roc Hyderabad & aged 13 years 2 months as per MCA records.
Frequently asked questions
Ekard Life Sciences is an active private limited company based in Secunderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 19 August 2013 (13+ years old) and is registered under CIN U24100TG2013PTC089575.
Ekard Life Sciences has 2 current directors:
- Jayantilal Bhandari - Director
- Borra Udayabaskar - Director
The latest financial statements of Ekard Life Sciences on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 29 September 2023. Year-wise statements from 2015 are in the company report.
The GSTIN of Ekard Life Sciences is 36AADCE4658C1ZS, registered in Telangana. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 37AADCE4658C1ZQ (Andhra Pradesh).
The CIN (Corporate Identification Number) of Ekard Life Sciences is U24100TG2013PTC089575. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ekard Life Sciences was incorporated on 19 August 2013, making it 13+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Ekard Life Sciences by revenue are Spenchem Pharmaceuticals Private Limited, Maxford Labs Private Limited, Fab Pharmaceuticals Private Limited, Zaneka Pharmaceuticals Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Borra Udayabaskar was appointed as Director on 19 Aug 2013. Jayantilal Bhandari was appointed as Director on 19 Aug 2013.
Yes, Ekard Life Sciences is registered as a micro enterprise under Udyam registration (number: UDYAM-AP-20-0001188).
The registered office of Ekard Life Sciences is at # 7 – 1 – 497 Monda Market Bandimetta, Secunderabad, Telangana, India – 500003.
Ekard Life Sciences operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages